Latest news
Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMTFirst-in-class small molecule inhibitor designed with AI support shows promise against pancreatic cancer in preclinical studies - Mayo Clinic News NetworkMayo Clinic News Network · Wed, 05 Aug 2026 13:41:08 GMTImmuneering Reports 17.3-Month Median Overall Survival in First-Line Pancreatic Cancer and Progresses Phase 3 MAPKeeper 301 Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:43:00 GMTIntermountain Health introduces new pancreatic cancer drug in western Colorado - KKCO 11 NewsKKCO 11 News · Sun, 02 Aug 2026 22:35:00 GMTIsraeli scientists launch worlds-first clinical trial for experimental pancreatic cancer treatment - The Jerusalem PostThe Jerusalem Post · Thu, 30 Jul 2026 07:00:00 GMT